A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

NCT03822871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: CTT1403
DRUG: CTT1057
DRUG: 68Ga-PSMA-11

Sponsor

Cancer Targeted Technology

Collaborators

[object Object]
[object Object]